"The Report Multiple
Sclerosis Market
in the US 2015-2019 provides information on pricing, market analysis,
shares, forecast, and company profiles for key industry participants.
- MarketResearchReports.biz"
Description
About Multiple Sclerosis
Multiple sclerosis is a chronic, inflammatory medical condition,
which results in demyelination, axonal transection, and
neurodegeneration of the nerve cells of the brain and spinal cord.
The immune system of the body targets the neurons within the CNS and
damages the myelin sheath. It is a potentially debilitating disease,
causing disruption in the communication and coordination functions of
the body. The symptoms of multiple sclerosis differ widely, subject
to the extent of damage and the number of neurons affected. Some of
the symptoms observed are fatigue, numbness, spasticity, bladder
dysfunction, cognitive changes, emotional changes, and depression. An
individual with severe form of the disease can experience speech and
movement problems. Multiple sclerosis can be broadly classified into
four types: RRMS, SPMS, PPMS, and PRMS.
Technavio's analysts forecast the multiple sclerosis market in the US
to grow at a CAGR of 3.8% over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of
the multiple sclerosis market in the US for the period 2015-2019. To
calculate the market size, the report considers revenue generated
from sales of various drugs used in the treatment of multiple
sclerosis.
The report also presents the vendor landscape and a corresponding
detailed analysis of the top vendors and competitive performances of
their product portfolios in the market. In addition, it discusses the
major drivers that influence the growth of the market. It also
outlines the challenges faced by vendors and the market at large, as
well as the key trends that are emerging in the market.
Technavio's report, the multiple sclerosis market in the US
2015-2019, has been prepared based on an in-depth market analysis
with inputs from industry experts. The report covers the multiple
sclerosis market in US market landscape and its growth prospects in
the coming years. The report also includes a discussion of the key
vendors operating in this market.
View Full Report at
http://www.marketresearchreports.biz/analysis/297185
Key Vendors
Bayer AG
Biogen
Merck Serono
Novartis AG
Teva Pharmaceutical Industries Ltd.
Other Prominent Vendors
AB Science
Abbvie
Acorda Therapeutics
Active Biotech
Artielle
Market Driver
Unmet Medical Needs.
For a full, detailed list, view our report.
Market Challenge
Unknown Disease Etiology.
For a full, detailed list, view our report.
Market Trend
Introduction of Disease-modifying Drugs.
For a full, detailed list, view our report.
Download
Sample copy of this Report at
Table of Content
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Product Profiles
05. Market Research Methodology
06. Introduction
07. Multiple Sclerosis: An Overview
08. Market Landscape
09. Market Segmentation by Route of Administration
10. Market Segmentation by Type of Molecule
11. Pipeline Portfolio
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
20. Key Vendor Analysis
21. Other Reports in This Series
Browse
Latest News at http://www.marketresearchreports.biz/articles
About Us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Browse
Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz
Browse Press Releases by
Prweb :
Contact Us
Office:
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel:
+1-518-621-2074
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment